Innate Pharma (IPHA) — Strategic Asset Allocation Index
Innate Pharma (IPHA) has a Strategic Asset Allocation Index of 202.0% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $10.39 Million) total $10.39 Million, measured against net assets of $5.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Innate Pharma to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Innate Pharma Strategic Asset Allocation Index (2015–2024)
This chart shows how Innate Pharma's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 202.0%, representing strategic assets of $10.39 Million against net assets of $5.14 Million USD. See IPHA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Innate Pharma (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Innate Pharma from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Innate Pharma (IPHA) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 116.4% | $10.28 Million | $- | $10.28 Million | $8.83 Million | ▲ +93.5 pp |
| 2023 | 22.8% | $9.80 Million | $- | $9.80 Million | $42.90 Million | ▼ -57.8 pp |
| 2022 | 80.6% | $43.66 Million | $8.54 Million | $35.12 Million | $54.15 Million | ▲ +34.0 pp |
| 2021 | 46.6% | $50.05 Million | $10.17 Million | $39.88 Million | $107.44 Million | ▲ +14.1 pp |
| 2020 | 32.5% | $50.63 Million | $11.69 Million | $38.93 Million | $155.97 Million | ▲ +10.1 pp |
| 2019 | 22.4% | $48.68 Million | $11.67 Million | $37.01 Million | $217.42 Million | ▼ -4.8 pp |
| 2018 | 27.1% | $45.40 Million | $10.22 Million | $35.18 Million | $167.24 Million | ▼ -55.7 pp |
| 2017 | 82.8% | $71.20 Million | $10.73 Million | $60.47 Million | $85.96 Million | ▲ +34.0 pp |
| 2016 | 48.8% | $42.07 Million | $9.09 Million | $32.98 Million | $86.17 Million | ▼ -10.8 pp |
| 2015 | 59.6% | $42.95 Million | $6.85 Million | $36.10 Million | $72.07 Million | — |